Summary: The structure of the periungual area is complicated, resulting in historically difficult morphological reconstruction after trauma or cancer resection. There is also no established standard for its reconstruction; thus, we aimed to use a full-thickness skin graft (FTSG) over the nail plate. Three patients with Bowen disease on their proximal nail fold (PNF) underwent excision with a 2-mm margin preserving the nail matrix, and a temporary wound dressing was applied. The FTSG was harvested from the ipsilateral ulnar wrist joint and placed over the skin defect, including the nail plate. Initially, the FTSG seemed to have shrunken; however, after 3 months, it extended and the PNF had a good color and texture match. Remarkably, the FTSG adhered to the nail plate, and the complex PNF structure appeared well reconstructed. Occasionally, a local flap is used; however, it is limited to small defects and causes a deformity of the periungual structure. In this study, the reconstructed PNF showed good results. We presumed that the bridging phenomenon caused graft survival on the nail plate, and that the presence of stem cells near the nail matrix caused graft extension and eponychium and cuticle regeneration. Specifically, the acquisition of sufficient raw surface around the nail plate and wound preparation after excision resulted in the former, and the nail matrix preservation after excision contributed to the latter. This surgical technique is simple and can therefore be considered a remarkably effective method for periungual area reconstruction to date.
Background: Gastrointestinal stromal tumor (GIST) is known to originate from the interstitial cells of Cajal or its precursors with a gain-of-function mutation of the c-kit or PDGFRA gene. GISTs are most commonly found in the stomach, followed by the small intestine. It is known that patients with intestinal GIST have markedly higher risks for recurrence compared to those with gastric GISTs. According to Miettinen's risk classification, intestinal GISTs are categorized in higher risk group compared with gastric GISTs at the same size and mitotic index. In this study, we sought to address mechanisms underlying the clinically malignant phenotype of intestinal GISTs. Methods: Fresh frozen samples of 6 primary gastric GISTs, 3 primary intestinal GISTs and 6 metastatic liver GISTs were utilized for cDNA microarray analysis. None of the patients had received imatinib therapy before surgery. Gene expression levels were compared between primary gastric and intestinal GISTs using gene set enrichment analysis (GSEA). Protein levels of SLIT2 were analyzed by immunohistochemistry in 25 primary gastric GISTs and 10 intestinal GISTs. Results: Microarray analysis of primary gastric and intestinal GISTs and metastatic liver GISTs classified them into two groups according their gene expressions. One group consisted of primary gastric GISTs without postoperative recurrence and the other consisted of clinically malignant GISTs, intestinal GISTs and metastatic liver GISTs, suggesting that intestinal GISTs potentially show gene expression profile similar to clinically malignant and metastatic GISTs. GSEA revealed that the gene set MITOTIC_CELL_CYCLE was upregulated in intestinal GISTs compared with gastric GISTs, consistent with previous reports that intestinal GISTs show higher mitotic count. The gene set NEURON_DIFFERENTIATION was downgulated in intestinal GISTs compared with gastric GISTs that may help explain mitosis-independent mechanisms underlying the clinically malignant phenotype of intestinal GISTs. In this gene set, we focused on SLIT2, downregulation of which has been reported to be associated with aggressive phenotypes in human cancers. Immunohistochemistry revealed that intestinal GISTs expressed lower SLIT2 protein than gastric GISTs, and that high-risk gastric GISTs and intestinal GISTs express comparable levels of SLIT2 protein which were lower than low-risk gastric GISTs. In SLIT2-high GISTs, tumor size was significantly smaller than in SLIT2-low GISTs, whereas mitotic counts and MIB-1 index were comparable among three groups according to SLIT2 intensity. Conclusions: Gene expression profile of intestinal GISTs was similar to that in metastatic liver GISTs. Expression levels of SLIT2 protein were lower in intestinal GISTs compared with gastric GISTs. Besides higher proliferative activity, downregulation of SLIT2 could be involved in clinically malignant phenotypes of intestinal GISTs. Citation Format: Hirotoshi Kikuchi, Ryuhei Hara, Shinichiro Miyazaki, Yoshihiro Hiramatsu, Kinji Kamiya, Manabu Ohta, Takanori Sakaguchi, Satoshi Baba, Haruhiko Sugimura, Hiroyuki Konno. Microarray analysis reveals distinct gene set profiles between gastric and intestinal gastrointestinal stromal tumors. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 2170. doi:10.1158/1538-7445.AM2015-2170
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.